Agios Pharmaceuticals Market Cap 2012-2020 | AGIO

Agios Pharmaceuticals market cap history and chart from 2012 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Agios Pharmaceuticals market cap as of December 03, 2020 is $3.22B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.223B $0.118B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.284B 34.44
Medtronic (MDT) Ireland $150.740B 30.64
Stryker (SYK) United States $86.808B 32.49
Boston Scientific (BSX) United States $48.184B 28.28
Lonza Group Ag (LZAGY) Switzerland $45.932B 0.00
Baxter (BAX) United States $38.572B 23.16
EssilorLuxottica Societe Anonyme (ESLOY) France $33.144B 0.00
ResMed (RMD) United States $30.665B 41.49
Zimmer Biomet Holdings (ZBH) United States $30.283B 24.93
Terumo (TRUMY) Japan $30.252B 38.67
Sunny Optical Technology (SNPTF) China $21.586B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.729B 0.00
Insulet (PODD) United States $17.311B 596.75
Bio-Rad Laboratories (BIO) United States $16.624B 63.04
DiaSorin S.p.A (DSRLF) Italy $11.581B 0.00
GN STORE NORD (GNNDY) Denmark $10.027B 51.11
Canopy Growth (CGC) Canada $9.920B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $9.045B 0.00
William Demant Holdings (WILYY) Denmark $8.605B 0.00
Quidel (QDEL) United States $7.949B 19.81
Perrigo (PRGO) Ireland $6.613B 11.65
Hill-Rom Holdings (HRC) United States $6.425B 17.39
Haemonetics (HAE) United States $5.715B 41.53
Envista Holdings (NVST) United States $4.800B 32.33
GW Pharmaceuticals (GWPH) United Kingdom $4.261B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.072B 0.00
ICU Medical (ICUI) United States $3.965B 29.76
Neogen (NEOG) United States $3.964B 64.99
TG Therapeutics (TGTX) United States $3.696B 0.00
National Vision Holdings (EYE) United States $3.462B 90.92
DFB Healthcare Acquisitions (AHCO) United States $3.179B 161.23
NanoString Technologies (NSTG) United States $2.407B 0.00
NuVasive (NUVA) United States $2.384B 34.43
Aphria (APHA) Canada $2.284B 0.00
AtriCure (ATRC) United States $1.946B 0.00
Owens & Minor (OMI) United States $1.900B 20.03
InMode (INMD) Israel $1.433B 32.24
Cardiovascular Systems (CSII) United States $1.392B 0.00
Quanterix (QTRX) United States $1.390B 0.00
Aurora Cannabis (ACB) Canada $1.378B 0.00
MacroGenics (MGNX) United States $1.331B 0.00
BioLife Solutions (BLFS) United States $1.145B 1166.33
Cerus (CERS) United States $1.135B 0.00
Lantheus Holdings (LNTH) United States $0.900B 16.02
OraSure Technologies (OSUR) United States $0.884B 0.00
PetIQ (PETQ) United States $0.834B 47.64
BellRing Brands (BRBR) United States $0.822B 34.75
Meridian Bioscience (VIVO) United States $0.818B 17.75
Omeros (OMER) United States $0.776B 0.00
LeMaitre Vascular (LMAT) United States $0.763B 40.31
Phibro Animal Health (PAHC) United States $0.741B 15.79
Varex Imaging (VREX) United States $0.647B 183.33
Vapotherm (VAPO) United States $0.644B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.609B 43.24
HEXO (HEXO) $0.517B 0.00
Surmodics (SRDX) United States $0.516B 315.83
Zynex (ZYXI) United States $0.467B 43.35
Viemed Healthcare (VMD) United States $0.375B 13.32
Cytosorbents (CTSO) United States $0.357B 0.00
Surface Oncology (SURF) United States $0.334B 0.00
InfuSystems Holdings (INFU) United States $0.332B 46.83
Utah Medical Products (UTMD) United States $0.319B 29.09
Organigram Holdings (OGI) Canada $0.297B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Bovie Medical (APYX) United States $0.254B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.225B 0.00
Chimerix (CMRX) United States $0.222B 0.00
Wound Management Technologies (SMTI) United States $0.217B 0.00
Female Health (VERU) United States $0.212B 0.00
Exagen (XGN) United States $0.180B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Chembio Diagnostics (CEMI) United States $0.131B 0.00
Evolus (EOLS) United States $0.124B 0.00
Fonar (FONR) United States $0.122B 17.89
Green Organic Dutchman Holdings (TGODF) Canada $0.111B 0.00
Rockwell Medical (RMTI) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Capricor Therapeutics (CAPR) United States $0.085B 0.00
MTech Acquisition (KERN) United States $0.073B 0.00
Brainsway (BWAY) Israel $0.070B 0.00
United-Guardian (UG) United States $0.066B 15.94
Nephros (NEPH) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Myomo (MYO) United States $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.023B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 8.17